Infinity Pharmaceuticals Inc (INFIQ)
0.00
USD |
OTCM |
May 01, 16:00
Infinity Pharmaceuticals Cash from Investing (TTM): 10.73M for June 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
June 30, 2023 | 10.73M |
March 31, 2023 | 14.01M |
December 31, 2022 | -0.055M |
September 30, 2022 | -0.055M |
June 30, 2022 | -10.80M |
March 31, 2022 | -14.08M |
December 31, 2021 | 5.489M |
September 30, 2021 | 22.71M |
June 30, 2021 | 13.73M |
March 31, 2021 | 19.70M |
December 31, 2020 | 14.63M |
September 30, 2020 | 6.912M |
June 30, 2020 | 4.649M |
March 31, 2020 | -4.199M |
December 31, 2019 | -12.24M |
September 30, 2019 | -21.74M |
June 30, 2019 | -20.43M |
March 31, 2019 | -0.294M |
December 31, 2018 | 13.10M |
September 30, 2018 | 12.84M |
June 30, 2018 | 0.768M |
March 31, 2018 | -16.49M |
December 31, 2017 | -4.278M |
September 30, 2017 | -7.257M |
June 30, 2017 | 26.10M |
Date | Value |
---|---|
March 31, 2017 | 80.81M |
December 31, 2016 | 40.33M |
September 30, 2016 | 11.22M |
June 30, 2016 | 37.47M |
March 31, 2016 | -74.52M |
December 31, 2015 | -37.90M |
September 30, 2015 | 25.74M |
June 30, 2015 | -14.24M |
March 31, 2015 | 103.53M |
December 31, 2014 | 117.85M |
September 30, 2014 | 136.54M |
June 30, 2014 | 162.62M |
March 31, 2014 | 80.84M |
December 31, 2013 | 0.606M |
September 30, 2013 | -64.97M |
June 30, 2013 | -140.98M |
March 31, 2013 | -123.56M |
December 31, 2012 | -62.00M |
September 30, 2012 | -86.87M |
June 30, 2012 | -22.32M |
March 31, 2012 | -14.34M |
December 31, 2011 | -13.69M |
September 30, 2011 | 37.42M |
June 30, 2011 | 27.89M |
March 31, 2011 | 37.41M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-21.74M
Minimum
Sep 2019
22.71M
Maximum
Sep 2021
1.704M
Average
4.649M
Median
Jun 2020
Cash from Investing (TTM) Benchmarks
Athersys Inc | 1.968M |
Merck & Co Inc | -14.08B |
MEI Pharma Inc | 58.90M |
Humanigen Inc | -- |
Bristol-Myers Squibb Co | -21.70B |